| Dr Ryan Kelly Good, DO | |
|
1008 Minnequa Ave, Pueblo, CO 81004-3733 | |
| (719) 776-8040 | |
| (719) 776-8050 |
| Full Name | Dr Ryan Kelly Good |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 9 Years |
| Location | 1008 Minnequa Ave, Pueblo, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922480730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | CDRH.0059610 (Colorado) | Primary |
| 207R00000X | Internal Medicine | CDRH.0059610 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Corwin Med Ctr, Centura Health | Pueblo, CO | Hospital |
| Centura Health-penrose St Francis Health Services | Colorado springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity - an important health strategy for managing diabetes, according to a study released by the Centers for Disease Control and Prevention in today's Morbidity and Mortality Weekly Report.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury, and brain trauma.
Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) being held in Orlando this week. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
› Verified 2 days ago
| Entity Name | Critical Care & Pulmonary Consultants, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033135520 PECOS PAC ID: 7315851953 Enrollment ID: O20031118000100 |
News Archive
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity - an important health strategy for managing diabetes, according to a study released by the Centers for Disease Control and Prevention in today's Morbidity and Mortality Weekly Report.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury, and brain trauma.
Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) being held in Orlando this week. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
› Verified 2 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity - an important health strategy for managing diabetes, according to a study released by the Centers for Disease Control and Prevention in today's Morbidity and Mortality Weekly Report.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury, and brain trauma.
Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) being held in Orlando this week. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
› Verified 2 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity - an important health strategy for managing diabetes, according to a study released by the Centers for Disease Control and Prevention in today's Morbidity and Mortality Weekly Report.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury, and brain trauma.
Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) being held in Orlando this week. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Kelly Good, DO Po Box 800022, Kansas City, MO 64180-0022 Ph: (800) 953-0104 | Dr Ryan Kelly Good, DO 1008 Minnequa Ave, Pueblo, CO 81004-3733 Ph: (719) 776-8040 |
News Archive
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity - an important health strategy for managing diabetes, according to a study released by the Centers for Disease Control and Prevention in today's Morbidity and Mortality Weekly Report.
Women who attain menopause between the age of 40 and 50 years need to watch out for cardiovascular disease (CVD), the risk being almost doubled in some groups of women according to a new University of Queensland study published October 3, 2019, in The Lancet Public Health. In absolute terms, the risk increased by 40% to 88% depending on the age of early menopause.
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury, and brain trauma.
Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) being held in Orlando this week. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.
› Verified 2 days ago
Nabila Naser, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-584-4000 | |
Shawn A. Koury, NP-C Hospitalist Medicare: Medicare Enrolled Practice Location: 1104 N Main St, Pueblo, CO 81003 Phone: 719-251-9023 | |
Harith Hilal Qureshi, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1008 Minnequa Ave, Pueblo, CO 81004 Phone: 719-557-4000 Fax: 719-557-4766 | |
Matthew W. Szymaszek, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-584-4306 Fax: 719-595-7886 | |
Kaykhosrow Hooshmand-parsi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 41 Montebello Rd Ste 116, Pueblo, CO 81001 Phone: 719-545-2746 Fax: 719-542-9638 | |
Dr. Krishna Chandra Mahat, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-584-4000 | |
Nisha Anu Prakash, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-584-4000 |